跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Mentopas - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Mentopas
Approved
STANDARD
Mentopas
Sinsin Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
cb9d0f41ae3539b6
Company
Sinsin Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
cb9d0f41ae3539b6
Drug Approval Philippines Name
Mentopas
Product Name
Mentopas
Registration Number
DRHR-396
Brand Name
Mentopas
Generic Name
Menthol + Methyl Salicylate + Camphor + Thymol + Borneol + Zinc Oxide
Dosage Form
Medicated Plaster
Dosage Strength
36.32 mg / 29.98 mg / 15.63 mg / 770 mcg / 1.20 mg / 17.17 mg
Manufacturer
Sinsin Pharmaceutical Co., Ltd.
Importer
LCIML, Inc.
Distributor
Philusa Corporation
Issuance Date
24 November 2022
Expiry Date
08 June 2027
Classification
Household Remedy (HR)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
cb9d0f41ae3539b6
Type
Standard
Back to Philippines FDA Approvals